When considering the intersection of vaccination timing and Cosentyx use, there are a few key points to keep in mind [1].

Cosentyx is a biologic medication used to treat conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis. Vaccinations, particularly live, attenuated vaccines, can pose risks for individuals taking immunosuppressive medications like biologics [2].

The decision on vaccination timing with Cosentyx use should be made in consultation with a healthcare provider. They will assess individual factors, such as the type of vaccine, the patient's underlying health, and the specific Cosentyx regimen being used [3].

According to the manufacturer, Pfizer, Cosentyx may increase the risk of infections, including those caused by live, attenuated vaccines [4]. The Centers for Disease Control and Prevention (CDC) generally recommends that individuals on biologics delay receiving live, attenuated vaccines for at least one to four weeks after last dose [5].

On the other hand, inactivated vaccines do not appear to pose the same risks as live, attenuated vaccines for individuals on biologics [6]. The CDC recommends following the recommended vaccination schedule for inactivated vaccines [7].

It's worth noting that the specific guidance on vaccination timing with Cosentyx use may change over time as more data becomes available [8].

Sources:

[1] https://www.drugpatentwatch.com/cosentyx/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434415/
[3] https://www.cosentyx.com/patient/en-US/safety.html
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434415/
[5] https://www.cdc.gov/vaccines/hcp/vis/vis-statements/live.html#tab-1
[6] https://www.cdc.gov/vaccinesafety/concerns/immunosuppression.html
[7] https://www.cdc.gov/vaccines/schedules/easy-to-read/child-adolescent.html
[8] DrugPatentWatch.com